Get the Stockscreener App
3.00
4.90%
0.14
Orasure Technologies Inc stock is traded at $3.00, with a volume of 369.91K.
It is up +4.90% in the last 24 hours and down -13.04% over the past month.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
See More
Previous Close:
$2.86
Open:
$2.86
24h Volume:
369.91K
Relative Volume:
0.51
Market Cap:
$219.41M
Revenue:
$405.47M
Net Income/Loss:
$53.66M
P/E Ratio:
4.1667
EPS:
0.72
Net Cash Flow:
$131.28M
1W Performance:
+8.70%
1M Performance:
-13.04%
6M Performance:
-21.05%
1Y Performance:
-29.08%
1-Day Range:
$2.85
$3.01
1-Week Range:
$2.755
$3.01
52-Week Range:
$2.36
$4.61
Orasure Technologies Inc Stock (OSUR) Company Profile
Name
Orasure Technologies Inc
Sector
Industry
Phone
(503) 641-6115
Address
220 E FIRST ST, BETHLEHEM, PA
Compare OSUR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OSUR
Orasure Technologies Inc
|
3.00 | 204.78M | 405.47M | 53.66M | 131.28M | 0.72 |
|
ISRG
Intuitive Surgical Inc
|
476.16 | 172.53B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
199.66 | 55.89B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
82.02 | 43.59B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
293.73 | 41.89B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
247.85 | 17.48B | 2.96B | 487.70M | 344.00M | 6.68 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-03-23 | Resumed | Evercore ISI | In-line |
| Sep-22-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-21-20 | Initiated | Evercore ISI | Outperform |
| Aug-10-20 | Initiated | Citigroup | Buy |
| Aug-10-20 | Initiated | JP Morgan | Neutral |
| Aug-07-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-25-20 | Initiated | Lake Street | Buy |
| Apr-21-20 | Resumed | Stephens | Equal-Weight |
| Oct-23-18 | Resumed | Raymond James | Mkt Perform |
| Jul-16-18 | Downgrade | Stephens | Overweight → Equal-Weight |
| Nov-02-17 | Downgrade | Jefferies | Buy → Hold |
| Feb-09-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-13-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-05-15 | Reiterated | Mizuho | Buy |
| May-07-15 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jan-23-15 | Reiterated | Mizuho | Buy |
| Jun-12-14 | Reiterated | Canaccord Genuity | Buy |
| Jun-11-14 | Reiterated | Mizuho | Buy |
| Dec-21-12 | Initiated | Mizuho | Buy |
| Aug-08-12 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Jul-05-12 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-27-12 | Initiated | JMP Securities | Mkt Outperform |
View All
Orasure Technologies Inc Stock (OSUR) Latest News
MACD Cross Could Confirm Trend in OraSure Technologies Inc.July 2025 PostEarnings & Stepwise Trade Signal Implementation - mustnews.co.kr
How to escape a deep drawdown in OraSure Technologies Inc.July 2025 WrapUp & Weekly Watchlist of Top Performers - Newser
Risk adjusted return profile for OraSure Technologies Inc. analyzedJuly 2025 Setups & High Conviction Investment Ideas - Newser
Global HIV Diagnostics Market to Grow at ~10% CAGR Driven by Rising Prevalence and POC Testing by 2030 - PharmiWeb.com
Key metrics from OraSure Technologies Inc.’s quarterly data2025 Support & Resistance & Advanced Technical Signal Analysis - Newser
Visual analytics tools that track OraSure Technologies Inc. performanceJuly 2025 Short Interest & AI Enhanced Execution Alerts - Newser
OraSure Technologies Inc. stock prediction for this weekPortfolio Risk Summary & Fast Moving Trade Plans - Newser
Long term hold vs stop loss in OraSure Technologies Inc.2025 Key Lessons & Free Reliable Trade Execution Plans - Newser
Will OraSure Technologies Inc. rebound enough to break evenWeekly Profit Recap & Stepwise Trade Signal Guides - Newser
Trend analysis for OraSure Technologies Inc. this weekTrade Exit Summary & Risk Controlled Stock Alerts - Newser
Is OraSure Technologies Inc. stock overhyped or has real potentialTreasury Yields & AI Powered Market Entry Ideas - Newser
Ranking OraSure Technologies Inc. among high performing stocks via toolsEntry Point & Long-Term Capital Growth Strategies - Newser
What momentum shifts mean for OraSure Technologies Inc.July 2025 Sector Moves & Risk Controlled Stock Alerts - Newser
OraSure Technologies Inc.’s volatility index tracking explained2025 Performance Recap & AI Powered Buy/Sell Recommendations - Newser
Will OraSure Technologies Inc. benefit from rising consumer demandTrade Entry Report & High Accuracy Buy Signal Tips - thegnnews.com
Is OraSure Technologies Inc. the Top Chart Pick This WeekTrade Entry Report & Risk Controlled Swing Alerts - metal.it
Visualizing OraSure Technologies Inc. stock with heatmaps2025 Price Targets & Risk Controlled Daily Plans - Newser
Orasure gets takeover bid proposal from Ron Zwanziger- Reuters - MSN
Why OraSure Technologies Inc. stock attracts strong analyst attentionQuarterly Profit Report & Stepwise Entry and Exit Trade Signals - thegnnews.com
OraSure Technologies Inc. Company’s Quarterly Earnings Growth: What the Numbers SayWeekly Stock Analysis & AI Based Buy/Sell Signal Reports - Newser
WisdomTree U.S. SmallCap Earnings Fund ETF Implied Analyst Target Price of $63.32 - AInvest
Will OraSure Technologies Inc. benefit from geopolitical trendsShare Buyback & Risk Controlled Daily Plans - sundaytimes.kr
Short Interest Drops in OraSure Technologies Inc. After RallyCapital Preservation Forecast Insight Prediction - beatles.ru
David Nierenberg's Q2 Moves: Concentrated Portfolio Sees Lyft and OraSure Additions, Cantaloupe Exit - AInvest
OraSure Technologies Inc. Recovery Hinges on Volume BreakoutLow Capital High Return Stock Plans Reviewed - 선데이타임즈
David Nierenberg Exits Cantaloupe Inc, Portfolio Down 10.6% - AInvest
Is this a good reentry point in OraSure Technologies Inc.Free Value Investing Picks With Stability - Newser
OraSure Technologies, Inc. (NASDAQ:OSUR) Analysts Are Pretty Bullish On The Stock After Recent Results - simplywall.st
OraSure Technologies, Inc. (NASDAQ:OSUR) Q2 2025 Earnings Call Transcript - Insider Monkey
OraSure (OSUR) Q2 Revenue Falls 43% - AOL.com
OraSure Technologies Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Orasure Technologies 2025 Q2 Earnings Deepened Losses Amid Sharp Revenue Drop - AInvest
OraSure Q2 Earnings Call: Revenue Growth, Innovation Progress, and Challenges Ahead - AInvest
OraSure reports second quarter earnings amid 'continued uncertainty' - WFMZ.com
OraSure’s Covid Come-Down Triggers Revenue Drop, But Outlook Brightens - Finimize
OraSure Technologies Q2 2025 Earnings: Revenue Down 43%, EPS Misses Expectations - AInvest
OraSure Reports Q2 Earnings in Line with Expectations, Raises Novel Blood Collection Device for Proteomic Research - AInvest
OraSure Technologies Q2 Financial Results: $19.7 Million LossNews and Statistics - IndexBox
OraSure Technologies Inc (OSUR) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
OraSure signals Q3 revenue outlook of $27M–$30M as it launches new proteomics product and completes manufacturing transition - MSN
OraSure Technologies Inc (OSUR) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
OraSure: Q2 Earnings Snapshot - Greenwich Time
OraSure Technologies Reports Q2 2025 Financial Results - TipRanks
OraSure's Strategic Transformation: A High-Conviction Play in the Evolving Diagnostics Sector - AInvest
Orasure Technologies Inc Stock (OSUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Orasure Technologies Inc Stock (OSUR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| EGLINTON MANNER CARRIE | President & CEO |
Feb 28 '25 |
Buy |
3.49 |
28,670 |
100,027 |
1,288,334 |
| EGLINTON MANNER CARRIE | President & CEO |
Feb 27 '25 |
Buy |
3.15 |
78,625 |
247,378 |
1,259,664 |
| Kenny John P. | Director |
Feb 27 '25 |
Buy |
3.17 |
47,659 |
151,217 |
70,915 |
| McGrath Kenneth J | Chief Financial Officer |
Feb 27 '25 |
Buy |
3.15 |
64,000 |
201,683 |
371,013 |
| Marmora Lelio | Director |
Feb 27 '25 |
Buy |
3.06 |
7,000 |
21,420 |
67,720 |
6.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):